As we near the end of 2024 and step into 2025, there are more innovative solutions revolutionizing how clinicians diagnose, treat, and manage gastrointestinal disorders. From AI-driven diagnostics to cutting-edge minimally invasive procedures, these technologies promise to enhance patient outcomes and redefine the boundaries of what’s possible in GI care.

In this blog, Invenia Group Associate Director Tanya Ridding explores the most impactful GI technologies that have helped shape the medtech industry in 2024.

 


 

Artificial Intelligence

AI-powered technology during colonoscopy screenings help detect lesions and provide a significant increase in ADR. Innovators include:

 

Non-invasive CRC screening

While colonoscopy remains the gold standard, up to 40% of people are not being routinely screened. Less invasive options can improve compliance and diagnosis.
Innovators include:

 

medical health

 

Capsule endoscopy

A swallowable pill containing a camera can aid diagnosis for cancers and GI diseases, particularly in the small bowel. Innovators include:

Barrett’s oesophagus

Barrett’s Oesophagus is often associated with GERD or chronic heartburn and can be a pre-cursor to oesophageal cancer, requiring surveillance. Innovators include:

Endoscopic ultrasound

EUS can detect GI diseases as well as those that cannot be detected from the GI tract alone, including pancreatic cancer. Innovators include:

 


 

Are you a MedTech company looking to hire? Submit your vacancy and a recruitment consultant that specialises in your field will be in touch shortly.

Alternatively, Register your CV with us today to schedule a confidential discussion about your career prospects.

Or, take a look at our MedTech or Executive Search industry pages to dive into the latest startup, funding or talent attraction data.